Ceftazidime CAS:72558-82-8

Ceftazidime is prescribed by healthcare providers to treat infections such as pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and meningitis caused by susceptible bacteria. Treatment with ceftazidime involves determining the appropriate dosage and duration based on the type and severity of the infection, as well as patient-specific factors. Patients typically receive ceftazidime through intravenous infusion or intramuscular injection under medical supervision to ensure proper administration and monitoring of treatment response. It is crucial for patients to adhere to the prescribed dosing schedule and complete the full course of treatment, even if symptoms improve, to effectively clear the infection and reduce the risk of developing antibiotic resistance. While generally well-tolerated, potential side effects of ceftazidime may include diarrhea, nausea, vomiting, and allergic reactions. Patients should be monitored for any adverse reactions during treatment, and any severe or persistent side effects should be reported to a healthcare provider for evaluation and management. Overall, ceftazidime is an important antimicrobial agent in clinical practice for treating bacterial infections when used appropriately under medical guidance.